DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

SPDR S&P Biotech (ETF) (NYSEMKT: XBI)

219.41 5.05 (2.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

XBI $219.41 2.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $215.67
Previous Close $214.36
Daily Range $215.51 - $220.47
52-Week Range $115.31 - $244.98
Market Cap $2.1B
Dividend (Yield) $0.98 (0.9%)
Volume 792,770
Average Daily Volume 879,130

News & Commentary Rss Feed

3 Biotech Stocks to Buy If the Sector Crashes

Our experts recommend Alnylam Pharmaceuticals, Celgene, and Biogen Idec.

A Bold Call On Biotech ETFs

A Buyback Or Biotech Bubble?

Use Options For a Chance To Buy BLUE at a 52% Discount

Markets Recover From Yemen Turmoil, Biotech Pain

Today's financial recap and tomorrow's financial outlook.

Sell-Off in Biotech, Semiconductor ETFs: A Nice Entry Point? - ETF News And Commentary

Thursday's ETF Movers: GDX, XBI

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

Wednesday's ETF Movers: OIH, XBI

Biotech Brutally Beaten by Big Beastly Bears

Today's financial recap and tomorrow's financial outlook.

XBI Is +24.22% YTD And +44.70% For 2014, But What Are The Risks?

See More XBI News...

Sector

Sector Equity

Industry

Health/Biotechnology Funds

SPDR S&P Biotech (ETF) (XBI) Description

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the biotechnology segment of a U.S. total market composite index. Website: http://www.spdrs.com/